1Yr·

Valuation Healthcare sector - Goldman Sachs

9
5 Comments

profile image
I still have one US pharma share on my buy list.
But I'm wondering whether I should get in before August.
•
2
•
profile image
@Tenbagger2024 I don't think anyone can answer that 😁. I think the healthcare sector for diversification is certainly not a mistake at the moment.
•
1
•
profile image
@BamBamInvest However, there will probably be significant gaps in developments between pharma, biotech, medtech and health insurers/healthcare.

For my taste, the assessments of the sector have been far too crude here recently and little substantiated information has been provided other than arguments of size and relevance for individual market players (cf. also LVMH hype a few months ago, where the key argument was always: hey, come on, it's LVMH, what could possibly go wrong🫣).
•
2
•
View one more answer
Deleted User
1Yr
Comment was deleted
profile image
@Michey777 I see it the same way 👌
••
Join the conversation